Leukemia: A Review of Data from the ASH 2022 Meeting

home / the-talk / leukemia-a-review-of-data-from-the-ash-2022-meeting

Expert hematologist/oncologists review key datasets in leukemia presented at the ASH 2022 Annual Meeting.

Supported in part by Amgen Oncology, Servier, and Takeda Oncology. Content developed independently by OncLive®.

Elias Jabbour, MD, an expert on leukemia

EP. 1: ASH 2022: Updates in the Acute Lymphocytic Leukemia Treatment Landscape

February 14th 2023

Following the ASH 2022 Annual Meeting, hematologic oncology experts discuss updated data in acute lymphocytic leukemia.

Anjali Advani, MD, an expert on leukemia

EP. 2: ASH 2022: Recent Advances in Chronic Myeloid Leukemia

February 14th 2023

Experts in hematologic oncology review and analyze updated data in chronic myeloid leukemia from ASH 2022.

Harry Erba, MD, PhD, an expert on leukemia

EP. 3: Acute Myeloid Leukemia: Updates From The ASH 2022 Annual Meeting

February 14th 2023

Shared insight on recently updated data in acute myeloid leukemia following the ASH 2022 annual meeting.